IDT Australia Ltd Net Assets
IDT Australia Ltd net assets. Based on the latest financial reports, IDT Australia Ltd (IDT) has net assets worth AU$21.89 Million AUD (≈ $15.49 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$36.92 Million ≈ $26.12 Million USD) and total liabilities (AU$15.03 Million ≈ $10.64 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore IDT Australia Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$21.89 Million |
| % of Total Assets | 59.28% |
| Annual Growth Rate | 6.11% |
| 5-Year Change | -20.74% |
| 10-Year Change | -49.54% |
| Growth Volatility | 27.67 |
Net Assets of IDT Australia Ltd (1989–2025)
Net assets of IDT Australia Ltd from 1989 to 2025. This chart illustrates how IDT Australia Ltd's net assets have evolved over time, based on quarterly financial data. See IDT Australia Ltd (IDT) net asset quality to measure how much of total assets are equity-financed.
Annual Net Assets for IDT Australia Ltd (1989–2025)
The table below shows the annual net assets of IDT Australia Ltd from 1989 to 2025. For live market cap and overall valuation, see IDT Australia Ltd (IDT) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$21.89 Million ≈ $15.49 Million |
-6.63% |
| 2024-06-30 | AU$23.44 Million ≈ $16.59 Million |
-2.90% |
| 2023-06-30 | AU$24.14 Million ≈ $17.08 Million |
-9.33% |
| 2022-06-30 | AU$26.62 Million ≈ $18.84 Million |
-3.59% |
| 2021-06-30 | AU$27.61 Million ≈ $19.54 Million |
+18.53% |
| 2020-06-30 | AU$23.30 Million ≈ $16.48 Million |
-6.85% |
| 2019-06-30 | AU$25.01 Million ≈ $17.70 Million |
-22.94% |
| 2018-06-30 | AU$32.46 Million ≈ $22.96 Million |
-33.65% |
| 2017-06-30 | AU$48.92 Million ≈ $34.61 Million |
+12.78% |
| 2016-06-30 | AU$43.38 Million ≈ $30.69 Million |
+10.64% |
| 2015-06-30 | AU$39.20 Million ≈ $27.74 Million |
+53.44% |
| 2014-06-30 | AU$25.55 Million ≈ $18.08 Million |
-1.84% |
| 2013-06-30 | AU$26.03 Million ≈ $18.42 Million |
-7.49% |
| 2012-06-30 | AU$28.14 Million ≈ $19.91 Million |
-6.13% |
| 2011-06-30 | AU$29.97 Million ≈ $21.21 Million |
-0.56% |
| 2010-06-30 | AU$30.14 Million ≈ $21.33 Million |
-11.90% |
| 2009-06-30 | AU$34.21 Million ≈ $24.21 Million |
+4.11% |
| 2008-06-30 | AU$32.86 Million ≈ $23.25 Million |
+8.13% |
| 2007-06-30 | AU$30.39 Million ≈ $21.50 Million |
+5.92% |
| 2006-06-30 | AU$28.69 Million ≈ $20.30 Million |
-1.56% |
| 2005-06-30 | AU$29.15 Million ≈ $20.62 Million |
+4.51% |
| 2004-06-30 | AU$27.89 Million ≈ $19.73 Million |
+5.60% |
| 2003-06-30 | AU$26.41 Million ≈ $18.69 Million |
+13.55% |
| 2002-06-30 | AU$23.26 Million ≈ $16.46 Million |
+13.62% |
| 2001-06-30 | AU$20.47 Million ≈ $14.48 Million |
+95.27% |
| 2000-06-30 | AU$10.48 Million ≈ $7.42 Million |
+40.47% |
| 1999-06-30 | AU$7.46 Million ≈ $5.28 Million |
+18.27% |
| 1998-06-30 | AU$6.31 Million ≈ $4.47 Million |
+10.42% |
| 1997-06-30 | AU$5.71 Million ≈ $4.04 Million |
+9.24% |
| 1996-06-30 | AU$5.23 Million ≈ $3.70 Million |
+4.95% |
| 1995-06-30 | AU$4.99 Million ≈ $3.53 Million |
+0.52% |
| 1994-06-30 | AU$4.96 Million ≈ $3.51 Million |
+104.41% |
| 1993-06-30 | AU$2.43 Million ≈ $1.72 Million |
+2.93% |
| 1992-06-30 | AU$2.36 Million ≈ $1.67 Million |
+33.92% |
| 1991-06-30 | AU$1.76 Million ≈ $1.25 Million |
-32.31% |
| 1990-06-30 | AU$2.60 Million ≈ $1.84 Million |
+0.42% |
| 1989-06-30 | AU$2.59 Million ≈ $1.83 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to IDT Australia Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 50592.7% over the analyzed period, potentially due to dividend distributions or operating losses.
IDT Australia Ltd Net Assets Breakdown (June 2025)
IDT Australia Ltd net assets breakdown by equity component as of June 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$64.19 Million | 293.27% |
| Other Comprehensive Income | AU$12.74 Million | 58.19% |
| Other Components | AU$1.00 | 0.00% |
| Total Equity | AU$21.89 Million | 100.00% |
IDT Australia Ltd Competitors by Market Cap
The table below lists competitors of IDT Australia Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
FIPP S.A.
PA:FIPP
|
$13.61 Million |
|
CMX GOLD+SILVER CORP.
F:6GS
|
$13.61 Million |
|
Leaders Cosmetics Co. Ltd
KQ:016100
|
$13.62 Million |
|
ReGen III Corp
V:GIII
|
$13.62 Million |
|
Vinpai SAS
PA:ALVIN
|
$13.60 Million |
|
KR Motors Co. Ltd.
KO:000040
|
$13.60 Million |
|
Pharma Equity Group A/S Cl A
CO:PEG
|
$13.60 Million |
|
Foxx Development Holdings Inc.
NASDAQ:FOXX
|
$13.59 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in IDT Australia Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 23,441,000 to 21,887,000, a change of -1,554,000 (-6.6%).
- Net loss of 8,063,000 reduced equity.
- Share repurchases of 6,653,000 reduced equity.
- New share issuances of 6,653,000 increased equity.
- Other comprehensive income increased equity by 20,999.
- Other factors increased equity by 6,488,001.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-8.06 Million | -36.84% |
| Share Repurchases | AU$6.65 Million | -30.4% |
| Share Issuances | AU$6.65 Million | +30.4% |
| Other Comprehensive Income | AU$21.00K | +0.1% |
| Other Changes | AU$6.49 Million | +29.64% |
| Total Change | AU$- | -6.63% |
Book Value vs Market Value Analysis
This analysis compares IDT Australia Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.88x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 4.16x to 0.88x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1989-06-30 | AU$0.01 | AU$0.05 | x |
| 1990-06-30 | AU$0.01 | AU$0.05 | x |
| 1991-06-30 | AU$0.01 | AU$0.05 | x |
| 1992-06-30 | AU$0.08 | AU$0.05 | x |
| 1993-06-30 | AU$0.11 | AU$0.05 | x |
| 1994-06-30 | AU$0.14 | AU$0.05 | x |
| 1995-06-30 | AU$0.14 | AU$0.05 | x |
| 1996-06-30 | AU$0.15 | AU$0.05 | x |
| 1997-06-30 | AU$0.15 | AU$0.05 | x |
| 1998-06-30 | AU$0.18 | AU$0.05 | x |
| 1999-06-30 | AU$0.22 | AU$0.05 | x |
| 2000-06-30 | AU$0.23 | AU$0.05 | x |
| 2001-06-30 | AU$0.42 | AU$0.05 | x |
| 2002-06-30 | AU$0.46 | AU$0.05 | x |
| 2003-06-30 | AU$0.53 | AU$0.05 | x |
| 2004-06-30 | AU$0.56 | AU$0.05 | x |
| 2005-06-30 | AU$0.63 | AU$0.05 | x |
| 2006-06-30 | AU$0.56 | AU$0.05 | x |
| 2007-06-30 | AU$0.61 | AU$0.05 | x |
| 2008-06-30 | AU$0.66 | AU$0.05 | x |
| 2009-06-30 | AU$0.68 | AU$0.05 | x |
| 2010-06-30 | AU$0.66 | AU$0.05 | x |
| 2011-06-30 | AU$0.64 | AU$0.05 | x |
| 2012-06-30 | AU$0.62 | AU$0.05 | x |
| 2013-06-30 | AU$0.54 | AU$0.05 | x |
| 2014-06-30 | AU$0.36 | AU$0.05 | x |
| 2015-06-30 | AU$0.28 | AU$0.05 | x |
| 2016-06-30 | AU$0.21 | AU$0.05 | x |
| 2017-06-30 | AU$0.19 | AU$0.05 | x |
| 2018-06-30 | AU$0.13 | AU$0.05 | x |
| 2019-06-30 | AU$0.10 | AU$0.05 | x |
| 2020-06-30 | AU$0.10 | AU$0.05 | x |
| 2021-06-30 | AU$0.12 | AU$0.05 | x |
| 2022-06-30 | AU$0.11 | AU$0.05 | x |
| 2023-06-30 | AU$0.10 | AU$0.05 | x |
| 2024-06-30 | AU$0.07 | AU$0.05 | x |
| 2025-06-30 | AU$0.05 | AU$0.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently IDT Australia Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -36.84%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -40.79%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 1.69x
- Recent ROE (-36.84%) is below the historical average (-0.28%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1989 | 7.53% | 3.55% | 1.19x | 1.78x | AU$-63.90K |
| 1990 | 3.38% | 1.67% | 1.20x | 1.69x | AU$-172.00K |
| 1991 | -47.73% | -21.99% | 1.19x | 1.83x | AU$-1.02 Million |
| 1992 | 8.44% | 5.03% | 1.16x | 1.44x | AU$-36.70K |
| 1993 | 16.08% | 8.76% | 1.26x | 1.46x | AU$147.40K |
| 1994 | 6.72% | 6.98% | 0.79x | 1.22x | AU$-162.90K |
| 1995 | 6.88% | 6.06% | 0.73x | 1.56x | AU$-155.50K |
| 1996 | 9.81% | 6.81% | 0.74x | 1.96x | AU$-10.19K |
| 1997 | 11.05% | 7.27% | 0.79x | 1.91x | AU$59.95K |
| 1998 | 14.13% | 0.00% | 0.00x | 1.97x | AU$260.85K |
| 1999 | 24.96% | 0.00% | 0.00x | 1.95x | AU$1.12 Million |
| 2000 | 28.66% | 19.78% | 0.82x | 1.76x | AU$1.96 Million |
| 2001 | 18.06% | 19.71% | 0.66x | 1.38x | AU$1.65 Million |
| 2002 | 18.15% | 20.22% | 0.64x | 1.41x | AU$1.90 Million |
| 2003 | 15.99% | 16.54% | 0.75x | 1.30x | AU$1.58 Million |
| 2004 | 15.27% | 16.88% | 0.69x | 1.31x | AU$1.47 Million |
| 2005 | 15.34% | 16.84% | 0.71x | 1.28x | AU$1.56 Million |
| 2006 | 12.59% | 14.56% | 0.70x | 1.23x | AU$743.80K |
| 2007 | 17.99% | 20.79% | 0.71x | 1.21x | AU$2.43 Million |
| 2008 | 21.64% | 23.03% | 0.73x | 1.29x | AU$3.82 Million |
| 2009 | 18.75% | 24.28% | 0.67x | 1.15x | AU$2.99 Million |
| 2010 | -5.23% | -13.34% | 0.36x | 1.10x | AU$-4.59 Million |
| 2011 | -0.79% | -1.85% | 0.39x | 1.08x | AU$-3.23 Million |
| 2012 | -6.53% | -18.73% | 0.31x | 1.13x | AU$-4.65 Million |
| 2013 | -20.57% | -50.54% | 0.34x | 1.18x | AU$-7.96 Million |
| 2014 | -25.93% | -49.54% | 0.47x | 1.11x | AU$-9.18 Million |
| 2015 | -7.63% | -19.03% | 0.36x | 1.10x | AU$-6.91 Million |
| 2016 | -9.24% | -52.64% | 0.14x | 1.22x | AU$-8.34 Million |
| 2017 | -1.58% | -8.10% | 0.16x | 1.19x | AU$-5.66 Million |
| 2018 | -52.31% | -131.70% | 0.33x | 1.20x | AU$-20.22 Million |
| 2019 | -24.32% | -50.15% | 0.39x | 1.25x | AU$-8.58 Million |
| 2020 | -8.24% | -13.61% | 0.49x | 1.23x | AU$-4.25 Million |
| 2021 | 7.62% | 13.15% | 0.47x | 1.24x | AU$-658.50K |
| 2022 | -4.36% | -9.58% | 0.40x | 1.13x | AU$-3.82 Million |
| 2023 | -35.20% | -122.54% | 0.25x | 1.17x | AU$-10.91 Million |
| 2024 | -23.09% | -40.93% | 0.42x | 1.34x | AU$-7.76 Million |
| 2025 | -36.84% | -40.79% | 0.54x | 1.69x | AU$-10.25 Million |
Industry Comparison
This section compares IDT Australia Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $28,519,958
- Average return on equity (ROE) among peers: -25.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| IDT Australia Ltd (IDT) | AU$21.89 Million | 7.53% | 0.69x | $13.61 Million |
| Althea Group Holdings Ltd (AGH) | $3.14 Million | -59.70% | 0.05x | $12.05 Million |
| BOD Science Ltd (BOD) | $4.81 Million | -100.25% | 0.85x | $3.01 Million |
| BPH Global Ltd (BP8) | $-76.25 Million | 0.00% | 0.00x | $2.35 Million |
| Cann Group Ltd (CAN) | $77.30 Million | -14.14% | 0.06x | $4.98 Million |
| ECS Botanics Holdings Ltd (ECS) | $3.87 Million | 13.02% | 0.04x | $5.65 Million |
| Ecofibre Ltd (EOF) | $109.94 Million | -13.34% | 0.36x | $5.36 Million |
| Epsilon Healthcare Ltd (EPN) | $22.32 Million | -52.32% | 0.25x | $5.51 Million |
| Elixinol Wellness Ltd (EXL) | $99.42 Million | 0.00% | 0.04x | $1.76 Million |
| Invion Ltd (IVX) | $12.14 Million | 0.00% | 1.00x | $2.24 Million |
About IDT Australia Ltd
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides medicinal cannabis and psychedelics; oral finished doses; and ase… Read more